GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic AS (OCSE:BAVA) » Definitions » Net Income From Continuing Operations

Bavarian Nordic AS (OCSE:BAVA) Net Income From Continuing Operations : kr1,321 Mil (TTM As of Mar. 2025)


View and export this data going back to 1998. Start your Free Trial

What is Bavarian Nordic AS Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Bavarian Nordic AS's net income from continuing operations for the three months ended in Mar. 2025 was kr219 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was kr1,321 Mil.


Bavarian Nordic AS Net Income From Continuing Operations Historical Data

The historical data trend for Bavarian Nordic AS's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic AS Net Income From Continuing Operations Chart

Bavarian Nordic AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 277.52 -464.78 -347.38 1,475.19 987.98

Bavarian Nordic AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -114.45 261.13 70.49 770.81 218.76

Bavarian Nordic AS Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1,321 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bavarian Nordic AS Business Description

Industry
Address
Philip Heymans Alle 3, Hellerup, DNK, 2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

Bavarian Nordic AS Headlines

No Headlines